Castleview Partners, LLC
Source: SEC Form 13F · as of Mar 2026Castleview Partners, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $15.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$15.8M
| Company | Shares | Value |
|---|---|---|
| BMYBRISTOL MYERS SQUIBB CO | 73,988 | $4.5M |
| AMGNAMGEN INC | 7,860 | $2.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,971 | $2.7M |
| ELVElevance Health Inc. | 5,056 | $1.5M |
| PMPhilip Morris International Inc | 5,033 | $832K |
| GILDGILEAD SCIENCES, INC. | 5,121 | $714K |
| JNJJOHNSON & JOHNSON | 2,914 | $712K |
| LLYELI LILLY & Co | 695 | $639K |
| PFEPFIZER INC | 16,262 | $457K |
| ZTSZoetis Inc. | 3,098 | $366K |
| IDXXIDEXX LABORATORIES INC /DE | 420 | $236K |
| GEHCGE HealthCare Technologies Inc. | 3,007 | $214K |
| ARCTArcturus Therapeutics Holdings Inc. | 16,857 | $130K |
| TNYATenaya Therapeutics, Inc. | 153,137 | $106K |
| RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. | 15,694 | $11K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.